fluconazole has been researched along with Liver Cirrhosis in 10 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| " dose of fluconazole were studied in parallel groups of ten normal subjects and nine patients with liver cirrhosis, a condition with a high risk of life-threatening fungal infection." | 7.69 | Single-dose pharmacokinetics of fluconazole in patients with liver cirrhosis. ( Hartmann, A; Pfaff, G; Ruhnke, M; Sarnow, E; Trautmann, M; Yeates, RA, 1995) |
| " dose of fluconazole were studied in parallel groups of ten normal subjects and nine patients with liver cirrhosis, a condition with a high risk of life-threatening fungal infection." | 3.69 | Single-dose pharmacokinetics of fluconazole in patients with liver cirrhosis. ( Hartmann, A; Pfaff, G; Ruhnke, M; Sarnow, E; Trautmann, M; Yeates, RA, 1995) |
| "Cryptococcosis is the third most common invasive fungal infection in solid-organ transplant recipients." | 2.72 | Successful Treatment of Pulmonary Cryptococcosis in a Liver Transplant Recipient Before and After Liver Transplant: Case Report and Literature Review. ( Liu, M; Liu, Y; Qu, W; Sun, LY; Wei, L; Zeng, ZG; Zhu, ZJ, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M | 1 |
| Sun, LY | 1 |
| Zhu, ZJ | 1 |
| Wei, L | 1 |
| Qu, W | 1 |
| Zeng, ZG | 1 |
| Liu, Y | 1 |
| Ha, MV | 1 |
| Choy, MS | 1 |
| McCoy, D | 1 |
| Fernandez, N | 1 |
| Suh, JS | 1 |
| Zhong, YH | 1 |
| Tan, F | 1 |
| Li, M | 1 |
| Liu, J | 1 |
| Wang, X | 1 |
| Yuan, Y | 1 |
| Zhong, XF | 1 |
| Peng, FH | 1 |
| Krashin, E | 2 |
| Lishner, M | 2 |
| Chowers, M | 2 |
| Reisfeld, S | 2 |
| Singh, N | 1 |
| Sifri, CD | 1 |
| Silveira, FP | 1 |
| Miller, R | 1 |
| Gregg, KS | 1 |
| Huprikar, S | 1 |
| Lease, ED | 1 |
| Zimmer, A | 1 |
| Dummer, JS | 1 |
| Spak, CW | 1 |
| Koval, C | 1 |
| Banach, DB | 1 |
| Shroff, M | 1 |
| Le, J | 1 |
| Ostrander, D | 1 |
| Avery, R | 1 |
| Eid, A | 1 |
| Razonable, RR | 1 |
| Montero, J | 1 |
| Blumberg, E | 1 |
| Alynbiawi, A | 1 |
| Morris, MI | 1 |
| Randall, HB | 1 |
| Alangaden, G | 1 |
| Tessier, J | 1 |
| Wagener, MM | 1 |
| Sun, HY | 1 |
| Wang, YC | 1 |
| Aruch, DB | 1 |
| Bhusal, Y | 1 |
| Hamill, RJ | 1 |
| Ruhnke, M | 1 |
| Yeates, RA | 1 |
| Pfaff, G | 1 |
| Sarnow, E | 1 |
| Hartmann, A | 1 |
| Trautmann, M | 1 |
| Levesque, H | 1 |
| Elie-Legrand, MC | 1 |
| Omnient, Y | 1 |
| Micaud, G | 1 |
| Lemeland, JF | 1 |
| Gancel, A | 1 |
| Courtois, H | 1 |
1 review available for fluconazole and Liver Cirrhosis
| Article | Year |
|---|---|
Successful Treatment of Pulmonary Cryptococcosis in a Liver Transplant Recipient Before and After Liver Transplant: Case Report and Literature Review.
Topics: Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Liver Cirrhosis; Liver Transplantati | 2021 |
9 other studies available for fluconazole and Liver Cirrhosis
| Article | Year |
|---|---|
Candida catenulata Candidaemia and Possible Endocarditis in a Cirrhotic Patient Successfully De-escalated to Oral Fluconazole.
Topics: Abdominal Pain; Administration, Oral; Adult; Antifungal Agents; Candida; Candidemia; Endocarditis; F | 2018 |
Comparisons of presentations and outcomes of cryptococcal meningitis between patients with and without hepatitis B virus infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Child; Cryptococcus; Female; Flucona | 2014 |
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Ascites; Ascitic Fluid; beta- | 2014 |
Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes.
Topics: Antifungal Agents; Cryptococcosis; Disease Progression; Female; Fluconazole; Humans; Liver; Liver Ci | 2015 |
Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy.
Topics: Antifungal Agents; Ascitic Fluid; Candida albicans; Escherichia coli; Fatal Outcome; Female; Flucona | 2015 |
Four-week fluconazole treatment is recommended for localized granulomatous cryptococcal prostatitis in patients with liver cirrhosis.
Topics: Aged; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Granuloma; Humans; Li | 2009 |
Unusual cause of cellulitis in a patient with hepatitis C and cirrhosis.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neof | 2011 |
Single-dose pharmacokinetics of fluconazole in patients with liver cirrhosis.
Topics: Adult; Case-Control Studies; Fluconazole; Humans; Liver; Liver Cirrhosis; Male | 1995 |
[Cryptococcus neoformans meningitis and cirrhosis. Value of fluconazole].
Topics: Aged; Aged, 80 and over; Cryptococcosis; Female; Fluconazole; Humans; Liver Cirrhosis; Meningitis | 1989 |